NCT06697418Enrolling by invitation
The Effect of Physical Activity Level Evaluated by Wrist-wearable Devices on Cardiovascular Disease Risk and Other Outcomes in Peritoneal Dialysis Patients
Source: ClinicalTrials.gov · Last updated 20 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to explore how daily physical activity (PA) levels affect the heart health and cognitive function of patients on peritoneal dialysis (PD). Using a fitness tracker, the investigators will measure how much patients move during the day and see if lower activity levels are linked to a higher risk of heart disease or memory issues. The study has two parts: Part A: The investigators will evaluate 266 patients to understand their current PA levels and how these relate to heart health and cognitive function. Part B: The investigators will follow the same patients over a year, measuring their activity at the beginning and after 12 months. The investigators will divide them into two groups-those who increase their PA and those whose PA decreases-and follow their heart health and memory function over two years. The goal is to understand whether higher PA levels can reduce the risk of heart problems and memory issues in PD patients.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 266 (estimated)
- First submitted
- 15 Oct 2024
- Start date
- 1 Oct 2024
- Primary completion date
- 1 Oct 2024
- Lead sponsor
- Ruijin Hospital
- Diseases
- Heart failure
- NCT number
- NCT06697418
What you commit to
- Study type: Observational
- Planned participants: 266
- From 1 Oct 2024 to the primary completion date, 1 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with newly diagnosed malignant tumors in the past year or undergoing radiotherapy or chemotherapy;
- NYHA class III or IV congestive heart failure, myocardial infarction, stable or unstable angina;
- New-onset stroke (within the past 3 months, including cerebral hemorrhage and cerebral infarction);
- Severe mental illness or a diagnosis of dementia.
Lab values
- Evidence of liver damage (ALT, AST≥ 2 times the upper limit of normal);
Other
- Unable or unwilling to provide written informed consent;
- Unwilling to cooperate with regular follow-up or telephone follow-up;
Who the study is looking for
- 18 years old or above, under 75 years old
- Receiving peritoneal dialysis treatment in Ruijin hospital for more than three months
- Having the ability to walk independently
- Willing to accept relevant training and sign informed consent
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ruijin Hospital Shanghai Jiaotong University School of Medicine Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.